Long-form, data-driven studies on 1.6M+ filings across 43 markets. Comparative regulation, walk-forward backtests, profiles, market mechanics.
Allianz held near 440.80 euros after a record Q2. Munich Re’s latest beat sets the peer backdrop, while insider filings stay quiet.
BNP Paribas rose after a 33% profit jump and a strong bank tape. The catch is simple: no fresh insider trades, only a modest 90-day buy tally.
Mandatum drew a clustered insider buy after Altor sold out. The stock sits near EUR 6.11 to 6.27, with wealth management momentum still doing the heavy lifting.
Fabege insiders bought through August as Stockholm property stayed soft. Here is what the cluster says, and where the case breaks down.
ABC Arbitrage’s August 21 insider sales came as volatility kept exchange volumes firm. Here is what the filings mean, and where they do not.
QinetiQ CEO Steve Wadey bought 145 shares on 20 August. Read the filing against a softer defense tape, BAE, Chemring and UK market support.
ALTEN’s Pascal Amore sold EUR 227,250 in August as Europe’s engineering and tech services names trade near highs and the ECB stays steady.
Publicis has outpaced the CAC 40 and WPP, but David Penski’s EUR 391,983 sale adds a cluster of insider selling to the story.
Wee Ee Chao and related holders sold about S$2.3m after UOB-Kay Hian’s H1 profit rose 66%. The business backdrop still matters.
Mitie CFO Simon Kirkpatrick sold 656,219 shares after nil-cost options vested. Read the filing against UK facilities management peers and macro.
GSK held near flat after July results, while AstraZeneca outperformed. The latest director buying adds context, not certainty, to the setup.
Unilever has volume-led growth, a fresh Galaxy Surfactants tie-up, and a quiet director filing record. Here is the bull case, the catch, and the insider read.